EVGN News
Evogene and Pure Capital Group Reach Cooperation Agreement to Resolve Differences and Reconstitute Board of Directors
Evogene and Pure Capital Group Reach Cooperation Agreement to Resolve Differences and Reconstitute Board of Directors Evogene and Pure Capital Group Reach Cooperation Agreement to Resolve Differences and Reconstitute Board of DirectorsPR NewswireREHOVOT, Israel, Oct. 6, 2026REHOVOT, Israel, Oct. 6...
PR Newswire
Evogene and Pure Capital Group Reach Cooperation Agreement to Resolve Differences and Reconstitute Board of Directors
Evogene and Pure Capital Group Reach Cooperation Agreement to Resolve Differences and Reconstitute Board of Directors Evogene and Pure Capital Group Reach Cooperation Agreement to Resolve Differences and Reconstitute Board of DirectorsPR NewswireREHOVOT, Israel, Oct. 6, 2026REHOVOT, Israel, Oct. 6...
PR Newswire
Evogene Gets 180-day Nasdaq Extension To Regain Compliance
(RTTNews) - Israeli computational chemistry company Evogene Ltd. (EVGN), announced on Wednesday that it has received an additional 180 days from Nasdaq to regain compliance with the minimum $1 bid price requirement...
Nasdaq News: Markets
Evogene Reports Nasdaq Grants Additional 180-Day Period to Regain Minimum Bid Price Compliance
Evogene Reports Nasdaq Grants Additional 180-Day Period to Regain Minimum Bid Price Compliance Evogene Reports Nasdaq Grants Additional 180-Day Period to Regain Minimum Bid Price CompliancePR NewswireREHOVOT, Israel, Sept. 30, 2026REHOVOT, Israel, Sept. 30, 2026 /PRNewswire/ -- Evogene Ltd...
PR Newswire
12 Health Care Stocks Moving In Tuesday's After-Market Session
Gainers
Evogene (NASDAQ:EVGN) shares increased by 75.0% to $0.72 during Tuesday's after-market session. The company's market cap stands at $4.5 million.
AIxCrypto Hldgs (NASDAQ:AIXC) stock moved upwards byread more...
Benzinga
Evogene Responds to Dissident Shareholders: Transformation and Commercial Progress Provide a Clear Path Forward
Evogene Responds to Dissident Shareholders: Transformation and Commercial Progress Provide a Clear Path Forward Evogene Responds to Dissident Shareholders: Transformation and Commercial Progress Provide a Clear Path Forward PR Newswire REHOVOT, Israel, Aug. 31, 2026 Company urges shareholders to...
PR Newswire
Evogene (EVGN) Q2 2026 Earnings Call Transcript
Evogene (EVGN) Q2 2026 Earnings Call Transcript...
Yahoo! Finance: News
Leading Independent Proxy Advisory Firms ISS and Glass Lewis Recommend Evogene Ltd. Shareholders Vote "FOR" the Company's Slate of Highly Qualified Director Nominees
Leading Independent Proxy Advisory Firms ISS and Glass Lewis Recommend Evogene Ltd. Shareholders Vote "FOR" the Company's Slate of Highly Qualified Director Nominees Leading Independent Proxy Advisory Firms ISS and Glass Lewis Recommend Evogene Ltd. Shareholders Vote "FOR" the Company's Slate of...
PR Newswire
Evogene Reports Second Quarter and First Half 2026 Financial Results
Evogene Reports Second Quarter and First Half 2026 Financial Results Evogene Reports Second Quarter and First Half 2026 Financial Results PR Newswire REHOVOT, Israel, Aug. 18, 2026 Company continues strategic transformation, initiated in 2025, into a focused, AI-driven computational chemistry...
PR Newswire